Researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer patients. Patients who have an undetectable level of PSA ...

Another participant with metastatic castration-resistant prostate cancer (mCRPC) in the Cohort Expansion Phase (Phase II; 8 GBq of 67 Cu-SAR-bisPSMA per cycle) of the SECuRE trial (NCT04868604) 1 ...

CHICAGO – Improved radiotherapy techniques have made it possible for men to achieve reductions in PSA to below detectable levels following radiation treatment for prostate cancer, according to new ...

Researchers, using an extremely sensitive tool based on nanotechnology, have detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical ...

SAN FRANCISCO—Prostate cancer patients who have undetectable PSA levels 10 years after undergoing a radical prostatectomy (RP) have a low likelihood of experiencing biochemical recurrence (BCR) of ...

Prognostic value of plasma vascular endothelial growth factor in hormone-sensitive advanced stage prostate cancer: An exploratory analysis No significant financial relationships to disclose. This is ...

Future Oncol. 2013;9(5):669-679. Three randomized clinical trials have dealt with the significance of ART in patients with locally advanced PC, namely: The ARO trial 96-02: [54] the primary end point ...

Androgen deprivation therapy (ADT) is administered to treat PSA recurrence following surgery or radiotherapy for prostate cancer. Men who achieve undetectable (<0.2 ng/ml) PSA levels within 8 months ...

Among men with PSA persistence after radical prostatectomy, a higher preoperative PSA surprisingly was linked to lower mortality. Men with PSA persistence and preoperative PSA >20 ng/mL had 31% lower ...

CHICAGO (November 2, 2009)––Fox Chase Cancer Center researchers report that radiation therapy alone can reduce prostate specific antigen (PSA) levels below detectable amounts in prostate cancer ...

A team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who ...